基于可解释PET生境与瘤周机器学习模型预测临床IA期纯实性非小细胞肺癌无进展生存:双中心研究
双中心回顾234例临床IA期纯实性非小细胞肺癌肺切除患者,提取PET瘤内、瘤周及生境区域影像组学特征,结合临床变量构建列线图,预测无进展生存。联合模型训练集AUC 0.905(95%CI 0.854-0.957),内部验证集AUC 0.875(95%CI 0.789-0.962)。生境与瘤周影像组学特征为独立生物标志物,模型可有效区分高、低风险患者。
要点
- 联合瘤周5 mm与生境区域影像组学的模型在训练集AUC 0.905、内部验证集AUC 0.875。
- 影像组学特征与无进展生存显著相关,模型可区分高、低风险患者。
- 低风险评分患者无复发生存期远长于高风险评分患者(log-rank P<0.001)。
核心结论
- 生境与瘤周影像组学特征可作为预测早期NSCLC无进展生存的独立生物标志物,有效对临床IA期纯实性NSCLC患者进行生存风险分层。
研究设计与样本
- 双中心回顾性研究,纳入234例因NSCLC接受肺切除的患者,从PET图像提取瘤内、瘤周及生境区域影像组学特征,采用单因素及多因素logistic回归确定显著临床变量,构建影像组学列线图,以Kaplan-Meier分析评估预后价值,并以SHAP解释机器学习模型。
诊断标准与关键数值
- 联合模型(含瘤周5 mm及生境区域影像组学特征与临床变量)训练集AUC 0.905(95%CI 0.854-0.957),内部验证集AUC 0.875(95%CI 0.789-0.962);低风险评分患者无复发生存期远长于高风险评分患者(log-rank P<0.001)。
临床应用与阅片要点
- 可利用基于PET生境及瘤周区域的影像组学列线图对临床IA期纯实性NSCLC患者进行无进展生存风险分层,低风险评分者无复发生存期远长于高风险评分者(log-rank P<0.001),SHAP可用于解释模型输出。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: This study aimed to develop and validate machine learning (ML) models utilizing positron emission tomography (PET)-habitat of the tumor and its peritumoral microenvironment to predict progression-free survival (PFS) in patients with clinical stage IA pure-solid non-small cell lung cancer (NSCLC).
MATERIALS AND METHODS: 234 Patients who underwent lung resection for NSCLC from two hospitals were reviewed. Radiomic features were extracted from both intratumoral, peritumoral and habitat regions on PET. Univariate and multivariate logistic regression analyses were employed to determine significant clinical variables. Subsequently, a radiomics nomogram was developed by combining the radiomics signature with these identified clinical variables. Kaplan-Meier (KM) analysis was performed to investigate the prognostic value of the nomogram. Shapley Additive Explanations (SHAP) were used to interpret the ML models.
RESULTS: The combination model which contained peritumoral 5 mm and habitat regions radiomics features, clinical variables obtained a strong well-performance, achieving area under the curve (AUC) of 0.905 (95% confidence interval (CI) 0.854-0.957) in the train set and 0.875 (95% CI 0.789-0.962) in the internal validation set. The radiomics signature was significantly associated with PFS, the model significantly discerned high and low-risk patients, and exhibited a significant benefit in the clinical use showed low-risk score given have far longer RFS than those with high-risk score (log-rank P<0.001).
CONCLUSION: The habitat and peritumoral radiomics signatures serve as an independent biomarker for predicting PFS in patients with early-stage NSCLC, effectively stratified survival risk among patients with clinical stage IA pure-solid non-small cell lung cancer.
引用
- Xue BH, Chen SL, Lan JP, et al. Explainable PET-Based Habitat and Peritumoral Machine Learning Model for Predicting Progression-free Survival in Clinical Stage IA Pure-Solid Non-small Cell Lung Cancer: A Two-center Study. Acad Radiol. 2025. PMID: 39757063. doi:10.1016/j.acra.2024.12.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。